Bill Phillips, technical lead for salt synthesis, says, "It’s a major milestone for American innovation and a clear signal of ...
Orum Therapeutics (Orum or the Company) (KRX: 475830), a biotechnology company pioneering the field of degrader-antibody conjugates (DACs), today announced the appointment of Chad May, Ph.D., as Chief ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback